Boeing (BA) shares experienced another decline this week, closing at $198.20 on Friday, September 18, marking a 4.83% drop over the past five trading days and a significant 12.98% decrease year to date. This latest downturn in the aerospace giant’s stock performance was primarily triggered by cautionary comments from CEO Kelly Ortberg at the prestigious Morgan Stanley Laguna Conference on September 16, where he outlined new challenges impacting the production ramps of the critical 737 and 787 programs, alongside a further postponement of the 777X certification testing into 2027. The news intensified investor caution already present due to Boeing’s ongoing struggle to demonstrate the feasibility of its ambitious turnaround plan, though some analysts viewed the market’s reaction as an overcorrection, presenting a potential buying opportunity.
Ortberg’s Candid Assessment at Laguna Conference
The Morgan Stanley Laguna Conference is a key event for investors and industry stakeholders, often serving as a platform for corporate leaders to provide updates on their companies’ performance and outlook. On September 16, Boeing CEO Kelly Ortberg addressed the audience, delivering a frank assessment of the company’s commercial aircraft programs. His remarks, while providing transparency, underscored the persistent operational hurdles Boeing continues to face across its core product lines.
A primary concern highlighted by Ortberg was the inability of the 737 production line to stabilize at the targeted rate of 47 jets per month. This particular bottleneck, according to Ortberg, stems from issues within Boeing’s in-house production of wings, rather than broader supply chain disruptions, which he noted were largely holding up. The 737 program, particularly the 737 MAX series, is central to Boeing’s commercial aircraft strategy and financial recovery. Following the two fatal crashes in 2018 and 2019 and the subsequent 20-month global grounding of the MAX fleet, Boeing has been under immense pressure to restore confidence in the aircraft and ramp up production to clear a substantial backlog of orders. The initial target of 52 jets per month, set before the grounding, has proven elusive, and even the adjusted target of 47 now faces delays. This impacts not only immediate revenue recognition but also the company’s ability to generate much-needed free cash flow, which has been severely constrained in recent years.
Despite the production challenges for existing variants, Ortberg did offer a sliver of positive news regarding the 737 MAX 10 variant. He indicated that its certification was "very soon," informing analysts that only "three deliverables to complete" remained when he departed Seattle. The MAX 10, the largest variant of the 737 MAX family, is crucial for Boeing to compete effectively with Airbus’s A321neo in the lucrative narrow-body market. Its timely certification is vital for securing new orders and retaining existing customers who might otherwise consider alternatives. The path to certification for any new Boeing aircraft has become significantly more rigorous under increased scrutiny from the Federal Aviation Administration (FAA) and other global regulators following the 737 MAX incidents.
Persistent Delays for the 777X Widebody
Beyond the narrow-body issues, Ortberg also confirmed further delays for Boeing’s next-generation widebody aircraft, the 777X. Certification testing for the twin-engine jet is now projected to extend into 2027, pushing the aircraft’s entry into service even further back. The 777X program has been plagued by delays for years, now approximately seven years past its original schedule. Initially launched in 2013 with much fanfare and substantial orders from major airlines like Emirates, Qatar Airways, and Lufthansa, the aircraft was originally slated for first delivery in 2020. This extended timeline presents significant challenges for Boeing’s financial planning, customer relations, and competitive standing in the long-haul market, where Airbus’s A350 is a strong contender.
A specific technical hurdle cited for the 777X’s prolonged certification process involves an engine seal issue on the GE Aerospace-built GE9X turbine, which powers the aircraft. The issue specifically pertains to its ETOPS (Extended-range Twin-engine Operational Performance Standards) certification, a critical regulatory approval that allows twin-engine aircraft to fly routes that are a specified distance from the nearest diversion airport. Without robust ETOPS approval, the aircraft’s operational flexibility and market appeal are severely limited.
In response to Ortberg’s comments, GE Aerospace (GE), the engine supplier, issued a statement asserting that certification can proceed with the existing seals and that upgraded parts began shipping in August. This suggests a potential disconnect or differing interpretation of the readiness between the airframer and its engine supplier, or perhaps a more conservative stance by Boeing in its projections to regulators and investors. The interplay between Boeing’s design and integration challenges and supplier-specific issues underscores the complexity of modern aircraft development and the extensive regulatory oversight now in place.
Broader Context: Boeing’s Turnaround Under Scrutiny
Boeing designs and builds a diverse portfolio of commercial jets, defense aircraft, and space systems. Consequently, any significant issue in the production ramp or certification timeline of its commercial programs directly affects its revenue stream, delivery schedules, and the commitments made to airline customers. The company has been under immense pressure for several years to prove that its comprehensive turnaround strategy is viable. This pressure stems not only from the 737 MAX groundings but also from a series of other challenges, including quality control issues on the 787 Dreamliner, which led to delivery halts and extensive inspections; cost overruns on defense contracts, such as the KC-46 tanker program; and persistent supply chain disruptions exacerbated by the global pandemic.
The 787 Dreamliner program, while not the primary focus of Ortberg’s recent comments, has also faced its share of production challenges. For over a year, starting in late 2020, Boeing halted 787 deliveries multiple times due to manufacturing flaws and quality control issues, which required extensive inspections and rework. These issues have resulted in substantial financial write-downs and delayed revenue recognition, further straining Boeing’s balance sheet. While Ortberg’s recent comments did not detail new specific 787 issues, the mention of "new challenges on the 787 production ramps" suggests that even this more mature program is not entirely free of operational headwinds. The cumulative effect of these production and certification delays across multiple key programs has severely hampered Boeing’s ability to convert its massive order backlog into revenue and much-needed cash flow.
Market Reaction and Analyst Perspectives
The immediate market reaction to Ortberg’s comments was swift and negative, with Boeing shares experiencing an intraday drop of approximately 7%. This amplified the existing downward trend for the week and year. However, not all market participants shared the same degree of pessimism. Ronald Epstein, a prominent aerospace analyst at Bank of America, viewed the selloff as an opportune moment to reiterate his "Buy" rating on Boeing shares, maintaining a $270 price target.
Epstein’s credibility among institutional investors is considerable; he has covered the aerospace and defense sector at Bank of America for over a decade and holds a five-star analyst rating from TipRanks. In a Bank of America Global Research report, Epstein described the market reaction as "a bit dramatic," arguing that setbacks in complex aircraft development and production programs were somewhat expected, especially given Boeing’s recent history and the ambitious nature of its recovery efforts. His perspective suggests a long-term view, focusing on Boeing’s fundamental strengths, such as its duopoly position with Airbus, its vast order backlog, and the eventual recovery of global air travel demand.
Epstein’s analysis likely factors in several considerations: the long-term demand for new aircraft, particularly in emerging markets; the strategic importance of Boeing to global defense and commercial aviation; and the belief that the company will eventually overcome its operational hurdles, albeit with a longer timeline than initially hoped. For analysts like Epstein, the current share price might represent a discount relative to the company’s intrinsic value once production stabilizes and new programs enter service.
However, other analysts and investors may hold a more cautious view. Concerns could include the prolonged cash burn associated with delayed programs, the potential for further erosion of customer confidence if delivery schedules continue to slip, and the increased risk of losing market share to competitors like Airbus, especially in the single-aisle segment where the A320/A321neo family has been highly successful. The financial implications of these delays are substantial, potentially leading to further debt accumulation or dilution through equity raises, impacting shareholder value in the short to medium term.
Implications for Boeing and the Aerospace Industry
The challenges flagged by CEO Kelly Ortberg carry significant implications for Boeing, its customers, and the broader aerospace supply chain. For Boeing, delayed deliveries mean deferred revenue recognition, impacting its financial statements and cash flow projections. The extended development and certification timelines also incur additional costs for testing, engineering, and maintaining production lines that are not yet operating at optimal efficiency. This financial strain complicates Boeing’s efforts to deleverage its balance sheet, which swelled significantly during the 737 MAX grounding and the pandemic.
For airline customers, these delays disrupt fleet planning, capacity expansion strategies, and efforts to modernize their fleets with more fuel-efficient aircraft. Airlines that have committed to the 777X, for example, have likely made long-term strategic decisions based on its original entry-into-service date. Further delays force them to adjust their operational plans, potentially extending the lifespan of older, less efficient aircraft or seeking alternative solutions, which can lead to increased operational costs and competitive disadvantages. While some airlines have contractual protections against such delays, the broader impact on trust and partnership remains a concern.
The aerospace supply chain, which consists of thousands of companies globally, also faces significant ripple effects. Fluctuating production rates and delayed program milestones create uncertainty for suppliers, making it difficult to plan production, manage inventory, and retain skilled labor. Many smaller suppliers are heavily dependent on Boeing’s production volumes, and prolonged instability can lead to financial distress within the supply base.
Looking ahead, Boeing’s path to recovery remains intricate and challenging. The company must not only address the specific production and certification issues highlighted by Ortberg but also continue to rebuild its relationship with regulators, restore customer confidence, and stabilize its financial performance. The ongoing global demand for new aircraft provides a strong underlying market, but Boeing’s ability to capitalize on this demand hinges on its operational execution. The coming quarters will be critical in determining if the company can indeed navigate these headwinds and fulfill the promises of its turnaround strategy, or if the current challenges signal a more prolonged period of operational and financial strain. Investors will be closely watching for signs of progress, particularly on the stabilization of the 737 production rate and concrete advancements in the 777X certification process, as these milestones are key to unlocking Boeing’s long-term value potential.
